In an ongoing phase 1 dose-escalation study evaluating the FSHR-directed CAR T-cell therapy lira-cel, the first case of stable disease has been reported in a patient with recurrent ovarian cancer #ovca #oncology

Read more on the ongoing study: www.onclive.com/view/fshr-di...

🇪🇺 The CHMP has has recommended EU marketing authorization for senaparib as a first-line maintenance treatment for advanced ovarian cancer, based on the phase 3 FLAMES trial.

Read more here 📈: www.onclive.com/view/eu-appr...

#ovca #oncology

🇪🇺 The CHMP has has recommended EU marketing authorization for relacorilant combined with nab-paclitaxel in platinum-resistant ovarian cancer, based on the phase 3 ROSELLA trial.

Full details ➡️: onclive.com/view/chmp-re...

#ovca #oncology

🗣️ OSE2101 Plus Pembrolizumab as Maintenance Boosts PFS in Platinum-Sensitive Ovarian Cancer

Read more here ➡️: www.onclive.com/view/ose2101...

#ovca #oncology